Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Government to plough up to £15.9m into training for pharmacists and pharmacy technicians

The English government has pledged to invest up to £15.9 million over the next four years into a programme to “enhance” pharmacists' and pharmacy technicians’ skills – including independent prescribing training for some pharmacists.

The additional funding, which comes from the pool of money set aside for the Pharmacy Integration Programme, will “allow for the expansion of frontline pharmacy staff in primary and community care”, Health Education England (HEE) said in a statement this morning (November 8).

NHSE&I and HEE will work in partnership to develop “a formal portfolio recognition process to identify the existing skills, training and experience gained by pharmacists working in primary care, allowing them to work more flexibly and better support GP services”, according to HEE.

The two bodies will also work on an independent prescribing training offer for community pharmacists and those working in general practice; “increase access to clinical training courses for pharmacy technicians in primary care”; and collaborate to expand training on clinical examination skills community pharmacists, HEE added.

An HEE spokesperson told C+D that more information on how pharmacists and pharmacy technicians will be able to access the education and training programmes will follow as HEE develops the offers.*


“Big difference” to career development


HEE director of national transformational programmes, Alan Ryan, said this investment will “make a big difference to the pharmacy workforce and career development in primary care”.

“New funded programmes will foster a range of skills and experiences to help pharmacists and pharmacy technicians thrive in multidisciplinary healthcare teams, and meet the demand for clinical care skills, prevention of ill-health and optimal outcomes from medicines in all NHS settings and at home,” he said.

Meanwhile, NHSE&I deputy chief pharmaceutical officer, Richard Cattell, added that the programme will help pharmacists and pharmacy technicians better integrate “into wider healthcare delivery as part of multi-professional clinical teams in primary care networks”.

“This structured postgraduate development demonstrates our commitment to ensuring existing registered pharmacy professionals have access to the same opportunities for further clinical training, including independent prescribing qualifications,” Mr Cattell added.

NHSE&I announced at the Pharmacy Show in Birmingham last month that it had decided to allocate some money from the Pharmacy Integration Fund (PhIF) to pay for the development of ICS-based community pharmacy integration leads.

The PhIF was introduced in 2016 to accelerate pharmacy’s integration with other parts of the healthcare system and to further integrate clinical pharmacy services into primary care networks. 



*This story was updated on November 9 to include additional information shared by HEE after publication

Do you think all community pharmacists should receive training to become independent prescribers?

Related Content


New Zealand
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts